US2019150816A1PendingUtilityA1
Blood clucose management system
Est. expiryAug 28, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61B 5/150251A61B 5/157A61B 50/3001A61B 5/15151A61B 2562/18A61B 5/150305A61B 5/15146A61B 5/14532A61B 5/150358A61B 2562/0295A61B 5/150572G01N 33/4875A61B 5/150022A61B 5/15087
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A biological property testing device includes a base comprising a primary surface extending in a base plane, and a first lancet station supported by the base. A first test strip channel provided in the base can have a main channel portion extending generally parallel with the base plane, and an angled channel portion that forms an angle with the main channel portion between 5 degrees and 90 degrees. The first test strip channel can house a biological test strip oriented so that a meter connecting end of the biological test strip is adjacent to the main channel portion and a sample end of the biological test strip is adjacent to the angled channel portion.
Claims
exact text as granted — not AI-modified1 . A biological property testing device carrier, comprising:
a base comprising a primary surface extending in a base plane; a first lancet station site provided in the base, the first lancet station site being configured to support a lancet station that includes a lancet; and a first test strip channel provided in the base,
the first test strip channel having
a main channel portion extending generally parallel with the base plane, and
an angled channel portion that forms an angle with the main channel portion between 5 degrees and 90 degrees,
the first test strip channel configured to house a biological test strip oriented so that a meter connecting end of the biological test strip is proximate to the main channel portion and a sample end of the biological test strip is proximate to the angled channel portion.
2 - 26 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.